Loading
Survivors who had chest radiotherapy as young women, or certain chemotherapies, have much higher risks of specific second cancers. They should be screened like people with inherited risk, and today most are not.
Women treated with chest radiotherapy before 30 have breast cancer risks comparable to BRCA carriers and are recommended annual MRI; survivors of Hodgkin lymphoma have elevated lung and gastrointestinal cancer risks; alkylating agents raise leukaemia risk. Uptake of recommended surveillance is low because survivors and their doctors do not know the exposures. Registry-driven identification and invitation to tailored screening, as is done for hereditary syndromes, would apply existing evidence.
Shares Ask whether survivorship screening saves lives, using registry-based randomisation, MRI, The hardest cancers are found late, Survivorship and late effects are neglected.
Shares Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards, Survivorship and late effects are neglected, HR-positive / HER2-negative breast cancer.
Shares Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards, Survivorship and late effects are neglected, Hodgkin lymphoma, HR-positive / HER2-negative breast cancer.
Shares Ask whether survivorship screening saves lives, using registry-based randomisation, Breast cancer after chest radiotherapy in childhood, and the screening that follows, Hodgkin lymphoma.
Shares Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards, Survivorship and late effects are neglected, Hodgkin lymphoma.
Shares The hardest cancers are found late, Survivorship and late effects are neglected.
Shares Ask whether survivorship screening saves lives, using registry-based randomisation, The hardest cancers are found late, Survivorship and late effects are neglected, Hodgkin lymphoma.
Shares Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards, Survivorship and late effects are neglected, HR-positive / HER2-negative breast cancer.